TWST

#1255
Twist Bioscience Corporation - Common Stock
66.8 7 USD
-3.13%
Sektör: Sağlık Hizmetleri
Baz: USD
Kar Para Birimi: USD
Günlük Aralık
66.87
66.87
Yıllık Aralık
23.30
69.20
Günlük Değişim
-3.13%
Aylık Değişim
+16.30%
6 Aylık Değişim
+114.05%
Yıllık Değişim
+133.73%
Önceki Kapanış
69.0 3
Open
66.8 7
Düşük
66.8 7
High
66.8 7
Hacim
165
Tam grafiği aç Full chart

Financials

Genel Bakış Tablolar İstatistikler
Çeyreklik Yıllık
  • Market Capitalization 4.16 B
  • Employee 979
  • Founded 2013
  • CEO Emily LeProust
  • Website www.twistbioscience.com
  • Headquarter Delaware, United States
  • FIGI BBG006KDCHJ4
  • Industry Tanı ve Araştırma
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-21.65
Fiyat/satışlar oranı
4.47

Twist Bioscience Corporation - Common Stock

Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck. The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox. In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.

Haberler